tiprankstipranks
Trending News
More News >

Ray Prudo Insider Profile

4 Followers
Ray Prudo, Director at Akari Therapeutics, holds 2.90M shares in Akari Therapeutics (Ticker: AKTX).
tipranks
Ray Prudo

Ray Prudo
Akari Therapeutics (AKTX)
Director

Not Ranked
Ray Prudo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Ray Prudo's holdings

Insider Roles

Akari Therapeutics
(AKTX)
Director
Roles that Ray Prudo holds in companies

Most Profitable Insider Trade

Stock:
Akari Therapeutics
(AKTX)
Rating:Informative Buy
Date:Sep 23, 2015 - Sep 23, 2016
Return:-68.60%
The most profitable trade made by Ray Prudo

Ray Prudo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Akari Therapeutics
Mar 10, 2025
Director
Uninformative Buy
500.00K
$2.69M
Success Rate for
AKTX
0 out of 1 profitable transactions on
AKTX
0%
Average Return for
AKTX
Average return per transaction on
AKTX
-68.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 23, 2015
Informative Buy
-
$524.00
-68.60%
Jun 04, 2024
Uninformative Buy
$0.00
-
$0.00
Dec 03, 2024
Uninformative Buy
$0.00
-
$0.00
Mar 10, 2025
Uninformative Buy
$500.00K
-
$1.12
List of latest transactions for each holding click on a transaction to see Ray Prudo's performance on stock

Ray Prudo insider profile FAQ

What is the percentage of profitable transactions made by Ray Prudo?
The percentage of profitable transactions made by Ray Prudo is ―.
    What is the average return per transaction made by Ray Prudo?
    The average return per transaction made by Ray Prudo is ―.
      What stocks does Ray Prudo hold?
      Ray Prudo holds: AKTX stocks.
        What was Ray Prudo’s latest transaction?
        Ray Prudo latest transaction was an Uninformative Buy of $500.00K.
          What was Ray Prudo's most profitable transaction?
          Ray Prudo’s most profitable transaction was an Informative Buy of AKTX stock on September 23, 2015. The return on the trade was -68.60%.
            What is Ray Prudo's role in Akari Therapeutics?
            Ray Prudo's role in Akari Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.